Brief: Dimerix Says Investigational New Drug Application For DMX-200 Approved
28/11/2023 01:41
Nov 28 (Reuters) - Dimerix Ltd DXB.AX :
* INVESTIGATIONAL NEW DRUG (IND) APPLICATION FOR DMX-200
APPROVED
BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION (NMPA)
Source text for Eikon: ID:nASX2f5LDF
Further company coverage: DXB.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dimerix
See all newsAustralia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region
Brief: Everest Medicine In Agreement With Dimerix To Develop Commercialize DMX-200 In Greater China, South Korea, And Southeast Asia
Brief: Dimerix Seeks Trading Halt
Brief: Dimerix To Conduct Review Of Action3 Statistical Assumptions